Medical Oncology

, 31:315 | Cite as

A difficulty in improving population survival outcome of gastric cancer in mainland China: low proportion of early diseases

  • Xin-Zu ChenEmail author
  • Wei-Han Zhang
  • Jian-Kun HuEmail author
Letter to the Editor

To the editor,

In Medical Oncology, a Chinese high-volume hospital’s experience typically represented the changes of surgical management for gastric cancer in mainland China [1]. Since the interim of first decade of twenty-first century, several Chinese surgeon communities of gastric cancer, such as gastric cancer committee in Chinese Anti-Cancer Association (CACA), made a great effort to spread standard gastric cancer surgery and advance the quality of radical D2 surgery in mainland China. Consequently, we found a dramatic increase in proportion of D2 surgery between two periods 2000–2005 and 2006–2010 [1]. Likewise, the average of harvested lymph nodes was obviously increased along with the promotion of technical quality [1]. Similar changes could be seen in other Chinese high-volume medical institutes nationwide, and the standard D2 surgery became the preferred treatment for resectable gastric cancer, including early gastric cancer (EGC). The promising alteration led to improvement...


Gastric Cancer Early Gastric Cancer Endoscopic Treatment Gastric Cancer Surgery Mass Health 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work was presented in part at the 10th International Gastric Cancer Congress (IGCC), Verona, Italy, June 19–22, 2013, and granted by the National Natural Science Foundation of China (No. 81301866 and 81372344).

Conflict of interest



  1. 1.
    Zhang WH, Chen XZ, Liu K, et al. Outcomes of surgical treatment for gastric cancer patients: 11-year experience of a Chinese high-volume hospital. Med Oncol. 2014;31(9):150.PubMedCrossRefGoogle Scholar
  2. 2.
    Chen XC, Chen XZ. Epidemiological differences in haematological malignancies between Europe and China. Lancet Oncol. 2014;15(11):e471–2.PubMedCrossRefGoogle Scholar
  3. 3.
    Wang R, Chen XZ. High mortality from hepatic, gastric and esophageal cancers in mainland China: 40 years of experience and development. Clin Res Hepatol Gastroenterol. 2014;. doi: 10.1016/j.clinre.2014.04.014.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Gastrointestinal Surgery, West China HospitalSichuan UniversityChengduChina

Personalised recommendations